ArticleCirculation. Heart failure2025

Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts.

Dorothea Kehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.